rewire.itbenchmarks
Configuration

MVP [MSAlign v2]

Exact Table 3 source implementation. Requires target molecular formula oracle.

3 evaluations · 9 results

Overview

Exact Table 3 source implementation. Requires target molecular formula oracle.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

3 evaluations · 9 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: MVP [MSAlign v2]Protocol: MSAlign v2 retrieval: massspecgym-formula-formula-oracle
Dataset subset: MSAlign v2 massspecgym-formula-formula-oracle
23.3 ± 3.4% recall_at_1
percent · higher

Uncertainty: type: standard_deviation; reported spread: 3.4; scope: Three random splitting seeds.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MVP massspecgym-formula-formula-oracle

Not reported

Aggregation: Not reported

MSAlign arXiv v2 Table 3 · Table 3 p7; massspecgym-formula block, R@1 row, MVP column
Configuration: MVP [MSAlign v2]Protocol: MSAlign v2 retrieval: massspecgym-formula-formula-oracle
Dataset subset: MSAlign v2 massspecgym-formula-formula-oracle
71.8 ± 0.6% recall_at_20
percent · higher

Uncertainty: type: standard_deviation; reported spread: 0.6; scope: Three random splitting seeds.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MVP massspecgym-formula-formula-oracle

Not reported

Aggregation: Not reported

MSAlign arXiv v2 Table 3 · Table 3 p7; massspecgym-formula block, R@20 row, MVP column
Configuration: MVP [MSAlign v2]Protocol: MSAlign v2 retrieval: massspecgym-formula-formula-oracle
Dataset subset: MSAlign v2 massspecgym-formula-formula-oracle
47.3 ± 2.0% recall_at_5
percent · higher

Uncertainty: type: standard_deviation; reported spread: 2.0; scope: Three random splitting seeds.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MVP massspecgym-formula-formula-oracle

Not reported

Aggregation: Not reported

MSAlign arXiv v2 Table 3 · Table 3 p7; massspecgym-formula block, R@5 row, MVP column
Configuration: MVP [MSAlign v2]Protocol: MSAlign v2 retrieval: massspecgym-mces-formula-oracle
Dataset subset: MSAlign v2 massspecgym-mces-formula-oracle
25.6 ± 0.8% recall_at_1
percent · higher

Uncertainty: type: standard_deviation; reported spread: 0.8; scope: Two MCES validation/test-swapped variants per methods, despite blanket three-split table caption.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MVP massspecgym-mces-formula-oracle

Not reported

Aggregation: Not reported

MSAlign arXiv v2 Table 3 · Table 3 p7; massspecgym-mces block, R@1 row, MVP column
Configuration: MVP [MSAlign v2]Protocol: MSAlign v2 retrieval: massspecgym-mces-formula-oracle
Dataset subset: MSAlign v2 massspecgym-mces-formula-oracle
79.9 ± 2.3% recall_at_20
percent · higher

Uncertainty: type: standard_deviation; reported spread: 2.3; scope: Two MCES validation/test-swapped variants per methods, despite blanket three-split table caption.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MVP massspecgym-mces-formula-oracle

Not reported

Aggregation: Not reported

MSAlign arXiv v2 Table 3 · Table 3 p7; massspecgym-mces block, R@20 row, MVP column
Configuration: MVP [MSAlign v2]Protocol: MSAlign v2 retrieval: massspecgym-mces-formula-oracle
Dataset subset: MSAlign v2 massspecgym-mces-formula-oracle
55.3 ± 0.1% recall_at_5
percent · higher

Uncertainty: type: standard_deviation; reported spread: 0.1; scope: Two MCES validation/test-swapped variants per methods, despite blanket three-split table caption.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MVP massspecgym-mces-formula-oracle

Not reported

Aggregation: Not reported

MSAlign arXiv v2 Table 3 · Table 3 p7; massspecgym-mces block, R@5 row, MVP column
Configuration: MVP [MSAlign v2]Protocol: MSAlign v2 retrieval: spectraverse-formula-oracle
Dataset subset: MSAlign v2 spectraverse-formula-oracle
9.6 ± 0.6% recall_at_1
percent · higher

Uncertainty: type: standard_deviation; reported spread: 0.6; scope: Three random splitting seeds.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MVP spectraverse-formula-oracle

Not reported

Aggregation: Not reported

MSAlign arXiv v2 Table 3 · Table 3 p7; spectraverse block, R@1 row, MVP column
Configuration: MVP [MSAlign v2]Protocol: MSAlign v2 retrieval: spectraverse-formula-oracle
Dataset subset: MSAlign v2 spectraverse-formula-oracle
48.3 ± 0.7% recall_at_20
percent · higher

Uncertainty: type: standard_deviation; reported spread: 0.7; scope: Three random splitting seeds.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MVP spectraverse-formula-oracle

Not reported

Aggregation: Not reported

MSAlign arXiv v2 Table 3 · Table 3 p7; spectraverse block, R@20 row, MVP column
Configuration: MVP [MSAlign v2]Protocol: MSAlign v2 retrieval: spectraverse-formula-oracle
Dataset subset: MSAlign v2 spectraverse-formula-oracle
25.9 ± 1.8% recall_at_5
percent · higher

Uncertainty: type: standard_deviation; reported spread: 1.8; scope: Three random splitting seeds.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

MVP spectraverse-formula-oracle

Not reported

Aggregation: Not reported

MSAlign arXiv v2 Table 3 · Table 3 p7; spectraverse block, R@5 row, MVP column

Source checking is not independent reproduction. Release 2026-09-30-e37e3ab1284d.

Use this model

How it works, versions and access

Related profile: MVP. This page retains the exact record and its evaluation context.

Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

1 evidence row matching the loaded filters

Claims, original sources and review scope · Release 2026-09-30-e37e3ab1284d
Property and statementOriginal source and locationReview and provenance
Relationship: variant of
uc20260930-model-mvp
Individual claims
MSAlign arXiv v2 Table 3

Original source ↗

Table 3 source column MVP; Section 5.1 Baselines

Version: 2605.19752v2, 25 September 2026
Retrieved: 2026-09-30

source checked

automated source review · 2026-09-30T21:40:59.576893+00:00

Audit details

Field: links:variant_of:uc20260930-model-mvp

Claim: uc20260930-config-family-489da5563a3dde1c

Source artifact SHA-256: a31d1167b0ded72f64717881dd6cba0946a56b495d76f169d8e44115c3266fda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

View linked audit checks and correction history

Release 2026-09-30-e37e3ab1284d · Record review: source checked

1 source records and release historyDownload this release
Technical metadata and extraction receipts

Stable ID: uc20260930-msalign-v2-config-mvp

areas
metabolomics
source locator
Table 3 column MVP; Sections 3 and 5.1
missing metadata
checkpoint hash: unextracted
review
method: automated_source_review; reviewer: Codex experimental-use-case curation; date: 2026-09-30; reviewed at: 2026-09-30T21:40:59.576893+00:00; scope: Primary-source transcription and catalogue applicability audit; not human scientific review or independent experimental reproduction.
reported name
MVP
Related records

Suggest a correction